C07D 487/10
Spiro-condensed systems
C07D487/10 (Spiro-condensed systems) appears on 1,174 US grants and 1,702 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,174
- Published applications
- 1,702
- Assignees
- 639
- Inventors
- 5,560
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 4 | 0 |
| 1978 | 9 | 0 |
| 1979 | 8 | 0 |
| 1980 | 9 | 0 |
| 1981 | 4 | 0 |
| 1982 | 3 | 0 |
| 1983 | 4 | 0 |
| 1984 | 6 | 0 |
| 1985 | 7 | 0 |
| 1986 | 6 | 0 |
| 1987 | 5 | 0 |
| 1988 | 4 | 0 |
| 1989 | 13 | 0 |
| 1990 | 11 | 0 |
| 1991 | 8 | 0 |
| 1992 | 15 | 0 |
| 1993 | 3 | 0 |
| 1994 | 4 | 0 |
| 1995 | 3 | 0 |
| 1996 | 3 | 0 |
| 1997 | 4 | 0 |
| 1998 | 7 | 0 |
| 1999 | 4 | 0 |
| 2000 | 5 | 0 |
| 2001 | 3 | 1 |
| 2002 | 6 | 3 |
| 2003 | 6 | 18 |
| 2004 | 5 | 17 |
| 2005 | 14 | 19 |
| 2006 | 9 | 26 |
| 2007 | 13 | 21 |
| 2008 | 9 | 31 |
| 2009 | 21 | 40 |
| 2010 | 21 | 32 |
| 2011 | 23 | 44 |
| 2012 | 21 | 31 |
| 2013 | 43 | 58 |
| 2014 | 52 | 73 |
| 2015 | 61 | 82 |
| 2016 | 58 | 73 |
| 2017 | 82 | 74 |
| 2018 | 56 | 80 |
| 2019 | 73 | 110 |
| 2020 | 70 | 83 |
| 2021 | 72 | 95 |
| 2022 | 50 | 97 |
| 2023 | 52 | 169 |
| 2024 | 81 | 154 |
| 2025 | 68 | 159 |
| 2026 | 55 | 112 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Processes for the preparation of substituted spirooxindole derivatives29 Sep 2026US 12,747,248 B2Enanta Pharmaceuticals, Inc.
- Indirubin derivatives having heterobicyclic moieties and the use thereof15 Sep 2026US 12,735,404 B2Pelemed Co., Ltd.
- N-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)-quinoline-4-carboxamides8 Sep 2026US 12,729,196 B2AstraZeneca AB
- Heterocyclic spiro compounds and methods of use8 Sep 2026US 12,729,207 B2Amgen Inc.
- Heterocyclic spiro compounds and methods of use1 Sep 2026US 12,723,047 B2Amgen Inc.
- Kif18a inhibitor compound, and pharmaceutical composition and preparation method therefor and use thereof1 Oct 2026US 2026/0294927 A1Changchun Genescience Pharmaceutical Co., Ltd.
- Inhibitors of spinster homolog 2 (spns2) for use in therapy1 Oct 2026US 2026/0297044 A1University of Virginia Patent Foundation
- Benzo-fused ring compound inhibitor, and preparation method therefor and use thereof1 Oct 2026US 2026/0297071 A1Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
- Sulfoximine compounds as histone deacetylase 6 inhibitor, and pharmaceutical composition comprising the same1 Oct 2026US 2026/0297073 A1Chong Kun Dang Pharmaceutical Corp.
- Polymorphic Compounds and Uses Thereof24 Sep 2026US 2026/0285871 A1Tyra Biosciences, Inc.
Most cited
By later US patents
- Cytotoxic agents170US 7,129,261 B2Medarex, Inc. · 2006
- Disulfide prodrugs and linkers and stabilizers useful therefor154US 6,989,452 B2Medarex, Inc. · 2006
- Peptidyl prodrugs and linkers and stabilizers useful therefor151US 7,087,600 B2Medarex, Inc. · 2006
- Pyrroloindole derivatives related to DC-88A compound113US 5,070,092 AKyowa Hakko Kogyo Co., Ltd. · 1991
- Peptidyl prodrugs and linkers and stabilizers useful therefor112US 7,507,420 B2Medarex, Inc. · 2009